What others say: Rescheduling marijuana could boost research

  • Monday, April 25, 2016 5:57pm
  • Opinion

The federal government says it’s
reviewing marijuana’s status as a Schedule 1 drug, a move that — regardless of what you think about the drug — is long overdue. The U.S. Drug Enforcement Agency made the announcement in a memo to lawmakers and said it hopes to have a decision ready sometime in the first half of this year.

Marijuana has long been classified as a Schedule 1 drug, but the classification is as ludicrous today as it was back in the day. The Schedule 1 category is for substances which are not considered to have “any currently accepted medical use in the U.S., a lack of accepted safety for use under medical supervision and a high potential for abuse.” By point of comparison, heroin also is a Schedule 1 drug.

There’s no reason for marijuana to be listed as a Schedule 1 drug — and, besides, that bit of business about not having any accepted medical use will come as a surprise to the millions of medical marijuana users in the United States.

There’s another reason why the Schedule 1 listing is vexing: It has needlessly complicated important scientific research, not just into marijuana, but also into industrial hemp, potentially a very useful crop. (Industrial hemp, which can be used for a variety of purposes, has very low levels of tetrahydrocannabinol — the substance that gets pot users high.) It was almost amusing to watch Oregon State University officials tip-toe around this issue last year before taking tentative steps to allow researchers there to work with industrial hemp. (To be fair, an institution such as OSU will be careful about working with a Schedule 1 drug, especially since it’s potentially putting millions of federal research dollars at risk.)

But there’s a lot of research yet to be done into the medicinal qualities of marijuana as well, and pulling pot off the Schedule 1 list would be a substantial step forward for that work.

A recent interview in The Oregonian with Dr. Colin Roberts, a pediatric neurologist and director of the Doernbecher Childhood Epilepsy Program at the Oregon Health and Science University, illuminated some of the issues researchers face. Roberts is working with a pharmaceutical company on a drug made with pure cannabidiol that has shown promise in treating patients with a form of epilepsy.

One big problem with the Schedule 1 designation is that it requires researchers to undergo a cumbersome approval process before working with a drug on the list. In the case of marijuana, researchers must use pot grown at a government-run facility at the University of Mississippi.

Researchers can’t just go out and buy pot at a dispensary, because there’s no way to verify precisely what they’re buying — and remember that different strains of marijuana have very different properties. Taking pot off the Schedule 1 list would allow researchers to obtain the sort of independent verification that’s essential for meaningful research.

“What we really need in the medical community is really good data,” Roberts told The Oregonian, “because if we don’t have that we will never understand the impact of these products good and bad.”

Pulling marijuana from the Schedule 1 list would be a first step toward getting that kind of good data. What’s the holdup?

—Corvallis Gazette-Times, April 21

More in Opinion

Nurse Sherra Pritchard gives Madyson Knudsen a bandage at the Kenai Public Health Center after the 10-year-old received her first COVID-19 vaccine on Friday, Nov. 5, 2021. (Camille Botello/Peninsula Clarion)
Alaska Voices: A mom’s and pediatrician’s perspective on COVID-19 vaccines for children

I want to see children and their parents who have yet to get vaccinated roll up their sleeves.

Gavel (Courtesy photo)
Opinion: The foolish men claiming self-defense

It’s not just misguided teenagers carrying guns who find themselves in trouble with the law.

Larry Persily (Peninsula Clarion file)
Opinion: State defends its right to cut nonexistent taxes

This from a state that has no property tax on homes or businesses, only on the oil industry.

Dr. Jay Butler, former chief medical officer for the State of Alaska, is seen in this undated photo. (Courtesy photo)
Alaska Voices: Feeling grateful this Thanksgiving for the COVID vaccines

The COVID vaccines remain our strongest tool in combating the pandemic and helping us return to our lives and the things we love and cherish.

A resident casts their vote in the regular municipal election Tuesday, Oct. 6, 2020 at the Kenai Peninsula Fairgrounds in Ninilchik, Alaska. (Photo by Megan Pacer/Homer News)
Voices of the Peninsula: All votes matter

In the beginning, only property-holding white men could vote.

Cristen San Roman. (Photo provided)
Point of View: Is management of Cook Inlet catered to special interest groups?

If these fish are so at risk, why is BOEM able to move forward with lease sale 258?

Homer Foundation
Point of View: Grateful for the hidden ‘good’

Gratitude: Noun The state of being grateful; thankfulness. The state or quality… Continue reading

Homer High School Principal Douglas Waclawski. (Photo provided)
Point of View: What is Homer High School about?

What I consider Homer High’s strength is that we are a place for learning.

UAA Chancellor Sean Parnell. (courtesy photo)
Alaska Voices: Invent your future at UAA

At UAA we’re providing the tools to help students of all ages and skills chart a new course forward.

A registered nurse prepares a COVID-19 vaccine at the pop-up clinic on the Spit on May 27. (Photo by Sarah Knapp/Homer News)
Alaska Voices: Vaccination is the still best protection from COVID-19

The Alaska State Medical Association encourages you to protect yourselves and your community from preventable illness by getting recommended vaccines.

(Ben Hohenstatt / Juneau Empire File)
The sad diminishment of Rep. Don Young

Young seems afraid to demand his party leader defend the dignity of the institution he loves.

A “Vote Here” sign is seen at the City of Kenai building on Monday, Sept. 21, 2020, in Kenai, Alaska. (Clarion file)
Alaska Voices: Restore our strong campaign donation limits

Without campaign spending limits, the ideal of one person, one vote is no longer really true.